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Abstract
Background: Malaria is more common in pregnant than in non-pregnant Nigerian women, and is associated with
small birth size and the attendant short- and long-term health risks. The influence of malaria on maternal
metabolic status in pregnancy and in cord blood and how this relates to birth size has not been studied. The
study objective was to define relationships between maternal and cord serum metabolic markers, maternal malaria
status and birth size.
Methods: During pregnancy, anthropometric measurements, blood film for malaria parasites and assays for lipids,
glucose, insulin and TNF were obtained from 467 mothers and these analytes and insulin-like growth factor-I (IGF-I)
were obtained from cord blood of 187 babies.
Results: Overall prevalence of maternal malaria was 52%, associated with younger age, anaemia and smaller infant
birth size. Mothers with malaria had significantly lower cholesterol (total, HDL and LDL) and higher TNF, but no
difference in triglyceride. In contrast, there was no effect of maternal malaria on cord blood lipids, but the median
(range) cord IGF-I was significantly lower in babies whose mothers had malaria: 60.4 (24,145)μg/L, versus no malaria:
76.5 (24, 150)μg/L, p = 0.03. On regression analysis, the key determinants of birth weight included maternal total
cholesterol, malarial status and cord insulin and IGF-I.
Conclusions: Malaria in pregnancy was common and associated with reduced birth size, lower maternal lipids and
higher TNF. In the setting of endemic malaria, maternal total cholesterol during pregnancy and cord blood insulin
and IGF-I levels are potential biomarkers of foetal growth and birth size.
Background
In Nigeria, increasing mortality from stroke and end-
stage renal failure is associated with a high prevalence
of hypertension, obesity, diabetes and high serum trigly-
cerides especially in women [1]. Numerous studies have
established associations between reduced birth weight
and increased risk of coronary heart disease, diabetes,
hypertension and stroke in adulthood [2,3]. Malaria
remains endemic in Nigeria and is more common
among pregnant women, with prevalence ranging from
20% to 44%. It leads to significant consequences for
maternal and infant health, such as maternal anemia,
responsible for 11% of maternal deaths, and low birth
weight (LBW), responsible for 5-12% of all LBW, 43% of
preventable LBW babies and contributes to 75,000-
200,000 infant deaths each year in Nigeria [4-9]. There-
fore, malaria in pregnancy may contribute to later life
morbidities in keeping with the ‘developmental origins’
hypothesis.
The biologic mechanisms underlying this hypothesis
are poorly understood and mediators of the relation-
ships between LBW, malaria in pregnancy and later car-
diovascular and metabolic morbidity have not been
clearly identified. Few studies have examined the rela-
tionships between maternal metabolic markers, foetal
hormones and birth weight, nor has the effect of malaria
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Maternal and cord blood levels of lipids, glucose and
insulin and cord insulin-like growth factor-I (IGF-I)
levels have been investigated as possible determinants of
birth weight [10-12]. Maternal fasting triglyceride (TG)
was independently associated with birth weight in non-
diabetic women with maternal hyperglycaemia and with
foetal growth and birth size in women with gestational
diabetes [11,13,14]. Maternal plasma glucose was posi-
tively associated with birth weight in non-diabetic
women [10,15]. The relationship between birth weight
and cord blood lipids was inconsistent [16,17], but posi-
tive correlations between birth weight and cord blood
glucose and insulin levels in both normal and low birth
weight babies have been reported [18]. Cord blood IGF-
I may also be involved in the control of foetal size dur-
ing late gestation [19,20]. Increased placental expression
of cytokines such as tumour necrosis factor (TNF),
interleukin 8, g-interferon, IL-6 and IL-10 occurred in
pregnancies affected by malaria, but only TNF has been
linked to LBW [21,22].
This study sought to explore the hypothesis that
malaria parasitaemia in pregnancy would induce changes
in maternal metabolic markers, which would be asso-
ciated with reduced birth size. The relationships
between maternal and cord blood metabolic profiles and
birth size in the setting of endemic malaria was exam-
ined and potential pregnancy biomarkers of LBW were
identified using an established cohort of mothers and
infants born in Nigeria. [23]
Methods
Study site
The study was carried out in Yemetu-Adeoyo, a semi-
urban community in Ibadan in south-west Nigeria
where transmission of malaria is perennial. The hospital
in this community, Adeoyo Maternity Hospital (AMH),
is the oldest maternity hospital in Nigeria, dating from
1927. There are over 4,000 deliveries annually. Ethical
approval for the study was obtained from the joint Uni-
versity of Ibadan/University College Hospital ethical
committee and the University of Manchester Ethics
committee.
Study procedures, follow-up, delivery and recruitment of
babies
Healthy pregnant women aged 18-45 years presenting at
AMH before 36 weeks’ gestation and all babies born ≥
37 weeks’ gestation were eligible. Women who were
HIV positive or had sexually transmitted infections at
booking, those with pre-term deliveries, as well as those
with multiple pregnancies or with chronic diseases, such
as hypertension and diabetes were excluded. Babies with
known syndromes, metabolic defects, major congenital
abnormalities or severe birth trauma were also excluded.
Standard operating procedures (SOP) were developed
and women were enrolled over one year to cover both
wet and dry seasons. The study protocol and the ratio-
nale for the study were explained carefully in appropri-
ate language, most commonly Yoruba or English, with
q u e s t i o n sa n s w e r e da sn e e d e da n dw r i t t e ni n f o r m e d
consent was obtained from all participants. After the
delivery of their babies, another written informed con-
sent was also obtained for the participation of the babies
in the study.
Information on socio-demographic, obstetric, family,
and health history including malarial frequency and use
of anti-malarial drugs, was collected. All participants
were issued prescriptions of sulphadoxine-pyrimetha-
mine for intermittent preventive therapy (IPT) for
malaria according to standard hospital practice.
Antenatal visits followed routine practice with fre-
quency of attendance determined by gestational age.
Standardized measures of anthropometry were carried
out on all women at every visit until delivery. Maternal
weight was measured to the nearest 0.1 kg on a SECA
scale, and height on a stadiometer, both without shoes
according to the SOP.
Visit schedule and blood measurements
At booking, 2 ml of blood was collected into an EDTA
tube for full blood count and blood films for malaria
parasites (MP) were prepared, stained with 3% Giemsa
at pH 7.2. Repeat thick blood films for MP were
obtained at every subsequent visit and at delivery. In
addition, the placenta was weighed, turned to the mater-
nal surface, cotyledons exposed and 1 ml of blood
obtained from the inter-villous space for a placental
malarial blood smear.
Blood films were examined for MP under light micro-
scopy and recorded as negative only after 100 or more
high-power microscope fields had been scanned. In
those with malaria, parasite densities were determined
by counting the number of parasites (np) among 200
leucocytes on the thick film using the following equa-
tion: Absolute parasite counts = (np x TLC)/200 where
TLC = subject’s total leucocyte count. For quality con-
trol, 30% of negative samples and 40% of positive sam-
ples were re-examined by two different, trained
microscopists.
At the second antenatal visit, of 624 healthy pregnant
women enrolled, 467 women gave their consent for fast-
ing blood to be taken for biochemical markers while
396 of them had samples for malaria parasites. At deliv-
ery, 27 were excluded due to four maternal deaths
(0.9%), 11 still births (2.4%), five miscarriages (1.1%) and
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pairs.
Cord blood was collected from the umbilical vein on
the foetal surface of the placenta. Plasma was separated
by centrifugation at 3,000 rpm and 4°C for 10 minutes
and aliquoted into microtubes and stored at -80°C prior
to lipid, glucose, insulin, TNF and IGF-I (cord blood
only) assays. Cord glucose could not be measured
immediately and so was not included in the assays.
Based on availability of complete maternal and cord
blood samples, 187 mother-baby pairs were selected.
There were no significant differences in the socio-demo-
graphic and clinical data of excluded women.
Definitions
Malaria was defined as the presence of asexual blood
stages of Plasmodium falciparum in peripheral blood.
There were two definitions of malaria:
a) ‘Malaria at recruitment’ = Malaria at second
antenatal visit when blood for biochemical markers was
also obtained. This was only used in analyses of effects
on maternal biochemical markers at the same time-
point. There were 72 blood smears positive for malaria
parasites out of the 396 samples giving the prevalence of
malaria as 18%.
b) ‘Maternal malaria’ = Malaria parasitaemia present
at least once during pregnancy and/or at delivery (n =
211). These included (i) malaria parasitaemia in periph-
eral blood at least once during pregnancy (n = 138); and
(ii) at delivery and/or in the placenta (n = 73). This was
used in analyses of relationships with cord parameters
and effects on birth indices.
Out of 187 mother-baby pairs with complete maternal
and cord blood samples, 97 had malaria giving a preva-
lence of 52%.
Anaemia was defined as a packed cell volume (PCV) <
30%.
Biochemical assays
Total cholesterol (TC), High-density lipoprotein-choles-
terol (HDL-C) and triglyceride concentrations were
determined by using standard enzymatic procedures on
an automatic analyser (COBAS MIRA/HITACHI 704 -
Roche Diagnostics, Germany). The inter- and intra-assay
coefficients of variation (CVs) for all parameters were <
5%. Low-density lipoprotein- cholesterol (LDL-C) was
calculated using the Friedewald formula [24].
The normal values of lipids (mmol/L) in adult women
are TC 3-5, HDL-C 1.2-2.2, LDL-C 2-3 and TG 0.6-1.68.
Maternal glucose was measured by the glucose oxidase
method using a commercial kit (Randox, Crumlin, UK)
on a YSI 2300 stat plus analyser (YSI, Farnborough,
Hants, UK). The intra-assay CV was 1.5% at 4.1 mmol/
L, and inter-assay CVs were 2.8% and 1.7% at 4.1 and
14.1 mmol/L respectively. Normal fasting glucose values
are 3.9-6 mmol/L.
Insulin was measured by ELISA, using a commercial
kit (Mercodia, Uppsala, Sweden). Assay sensitivity was 1
mU/L. Intra-assay CVs were 3.4% and 3.2% at 11 and
154 mU/L, and equivalent inter-assay CVs were 3.6%
and 2.9%.
IGF-I and TNF were measured using Immulite 2000
assays (DPC, Lumigen Inc, Southfield, UK). Respective
assay sensitivities were 25 μg/L and < 0.09 ng/L. Inter-
assay CV values for IGF-1 at 48.9 and 158.5 μg/L were
7.6 and 9.2%. For TNF, intra-assay CVs were 6.7% and
5.3% at 6.3 and 19 ng/L, and the inter-assay CVs at 6.1
and 18.6 ng/L were 8.2 and 9.7% respectively.
Infant anthropometry
Babies were measured within 72 hours of birth. They
were weighed naked to the nearest 0.1 kg and length
measured on an infant stadiometer from crown to
heel to the nearest 0.1 cm. Occipito-frontal circumfer-
ence (OFC) was taken around the widest circumfer-
ence of the head using a non-stretchable tape.
Skinfold thicknesses (triceps, biceps, sub-scapular, and
suprailiac) were measured using Holtain calipers on
the left side to the nearest 0.1 mm. Measurements
were obtained in duplicate or triplicate if disagreeing
by > 15%.
Validity of anthropometric measurements
Based on the WHO Manual (1995), three nurses,
already proficient in paediatric venipuncture, were
trained in anthropometry methods. They carried out all
measurements on the same equipment throughout the
study. They also had three-monthly protocol-refresher
training sessions and used training videos to minimize
inter-observer and within-observer errors.
Statistical analysis
Data were analysed using SPSS version 14 (SPSS Inc,
Chicago, IL). Results were expressed as mean (SD) or
median (IQ range), using Student t/Mann Whitney and
Chi square tests for associations between maternal and
infant clinical characteristics and malaria. Levels of
insulin, IGF-I and TNF were skewed and, therefore,
tested non-parametrically, while lipids and glucose levels
were normally distributed and tested parametrically.
Correlations were assessed by Spearman’s test. All tests
w e r et w o - s i d e da n dpv a l u e s<0 . 0 5w e r ec o n s i d e r e d
significant.
Simple linear regression was used to assess the deter-
minants of infant size, indicating those with p < 0.001, p
< 0.01 and < 0.05. Due to high co-linearity between bio-
chemical parameters, a stepwise method of model selec-
tion was used to identify the key variables.
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The age and BMI of mothers were similar irrespective of
trimester at recruitment. Mean (SD) gestational ages at
booking and at delivery were 27.1 (5.1) and 39.3 (1.4)
weeks respectively (Table 1).
Plasma levels of all lipids except HDL-C were signifi-
cantly elevated in the third compared to the second tri-
mester but fasting plasma glucose was reduced. Insulin
and TNF levels were similar.
Effect of maternal malaria at recruitment on maternal
characteristics and biochemical markers
The prevalence of malaria among the women at recruit-
ment was 18%. Among all women recruited, 28% were
primigravid, and this was associated with MP (28% vs
13% in the multigravid, p = 0.001). Primigravidity was
associated with 2.5-fold increase in risk of having
malaria [OR = 2.5, 95% CI, 1.5-4.2].
Most women were asymptomatic and only seven had
fever. Malaria was also associated with younger maternal
age (29.4 vs 27.7 years, p = 0.001) and lower packed cell
volume [31.7 (4.7) vs 32.8 (3.3)%, p = 0.006].
Mothers with malaria had significantly lower TC,
lower HDL-C, lower LDL-C, no change in TG but
higher TNF in both the second and third trimesters
(Table 2). There was no difference in glucose and insu-
lin levels in the two trimesters with the presence of MP.
Effect of maternal malaria on newborn birth indices and
cord blood biochemical markers
Prevalence of maternal malaria defined as malaria in
pregnancy and/or at delivery overall was 52%. Mean
birth weight, length, OFC, mid-upper arm circumference
(MUAC) and biceps skinfold thicknesses of infants born
to women with malaria were globally smaller than those
of women without malaria. Mean birth weight was sig-
nificantly lower by 160 gms (-5.3% compared to babies
of mothers without malaria), biceps skinfold thickness
by 1.5 mm (-4.1%) and MUAC by 1.8 mm (-1.8%), while
birth length and OFC were lower by only 6.2 cm (-1.3%)
and by 3.5 mm (-1%) respectively (Table 3). The placen-
tal weights of infants born to women with and without
malaria were not significantly different but the placenta-
foetal weight ratios for infants whose mothers have
m a l a r i aw e r es i g n i f i c a n t l yl o w e rt h a nt h o s ew h o s e
mothers did not have malaria (p = 0.019) (Table 3).
Cord blood IGF-I levels were significantly lower in
babies of mothers with malaria, with no differences in
cord blood lipids, insulin and TNF (Table 4).
Associations of maternal and cord biochemical markers
and maternal malaria with infant size
Maternal total cholesterol and LDL-C were significantly
correlated with birth weight at p < 0.001 and insulin at
p < 0.01 (Table 5), while maternal TG and glucose and
c o r db l o o di n s u l i na n dI G F - Ic o r r e l a t e dw i t hb i r t h
weight at p < 0.05 (Table 5).
To determine the overall independent effects on birth
weight, three stepwise regression models were derived
(Table 6):
1 In the first model, the influence of malaria at
recruitment and all maternal biochemical markers on
birth weight was evaluated. Maternal TC was a power-
ful, independent determinant of birth weight (p =
0.001), such that for every 0.15 mmol/L increase in TC,
there was a 100 g increase in birth weight.
Table 1 Maternal clinical characteristics and biochemical markers at recruitment
Parameter (n = 467) Trimester 2
n = 125
Trimester 3
n = 342
P value
a, b
Age (year) 29.0 (4.9) 28.5 (5.3) 0.280
Gestational age (weeks) 22.8 (3.2) 31.9 (3.3) < 0.001
BMI (kg/m
2) 25.2 (3.9) 24.9 (3.9) 0.501
Total cholesterol (mmol/L) 4.44 (3.93, 5.45) 4.98 ((4.28, 5.69) 0.002
HDL-C (mmol/L) 1.54 (1.27, 1.83) 1.55 (1.27, 1.81) 0.922
LDL-C (mmol/L) 2.49 (1.97, 3.13) 2.74 (2.17, 3.25) 0.021
Triglyceride (mmol/L) 1.31 (1.05, 1.51) 1.47 (1.23, 1.79) < 0.001
Glucose (mmol/L) 4.33 (4.04, 4.55) 4.13 (3.87, 4.41) < 0.001
Insulin (mU/L) 4.32 (2.76, 6.90) 3.92 (2.21, 6.09) 0.204
TNF (ng/L) 0.17 (0.09, 0.83) 0.35 (0.09, 0.83) 0.102
Insulin (mU/L) 4.32 (2.76, 6.90) 3.92 (2.21, 6.09) 0.204
TNF (ng/L) 0.17 (0.09, 0.83) 0.35 (0.09, 0.83) 0.102
Variables expressed as either Mean (SD) or Median (IQ Range)
a Student t test done for variables presented as mean (SD);
bMann Whitney U test for variables presented as median (IQ range)
BMI, Body mass index; HDL-C, High-density lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-cholesterol; TNF-a, Tumour necrosis factor-alpha
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malaria through pregnancy and at delivery and all cord
biochemical markers on birth weight was examined.
Maternal malaria was the only significant determinant
of birth weight (p = 0.007).
3 In the final model, maternal malaria, and maternal
and cord biochemical markers that had shown signifi-
cant correlations to birth weight were included. Mater-
nal malaria with cord blood insulin and IGF-I were
significantly related to birth weight.
Discussion
Effect of maternal malaria on maternal and cord blood
biochemical markers
In agreement with other studies in various populations,
including Nigerian pregnant women, this study showed
an overall elevation in serum lipids, except HDL-C, dur-
ing pregnancy. The elevation was highest in the third
trimester [25-27]. Jimenez et al reported no significant
changes in HDL-C during pregnancy while others report
an elevation [28,29]. These increases in TC and LDL-C
and low to normal HDL-C are believed not to be
atherogenic [25,27] and are likely to be related to energy
transfer to the foetus. The cord lipid profiles are similar
to those in Manchester children from the hyperglycae-
mia and adverse pregnancy outcomes (HAPO) study
Table 2 Effect of malaria at recruitment on maternal biochemical markers
Maternal Biochemical
Markers
Trimester 2
n = 110
P value Trimester 3
n = 286
P value
Total n = 396 Malaria Absent
n=9 3
Malaria Present
n=1 7
Malaria Absent
n = 231
Malaria Present
n=5 5
TC (mmol/L) 4.73(4.26,5.71) 3.73(2.80,4.28) < 0.001 5.17(4.50,5.81) 4.43(3.67,5.41) < 0.001
HDL-C (mmol/L) 1.58(1.37,2.02) 0.86(0.70,1.38) < 0.001 1.64(1.39,1.84) 1.27(0.97,1.63) < 0.001
LDL-C (mmol/L) 2.66(2.03,3.28) 2.10(1.51,2.53) 0.010 2.77(2.31,3.43) 2.44(1.70,3.08) 0.006
TG (mmol/L) 1.29(1.02,1.51) 1.35(1.19,1.62) 0.112 1.47(1.24,1.77) 1.51(1.28,1.99) 0.125
Glucose (mmol/L) 4.31(4.06,4.58) 4.40(3.89,4.48) 0.795 4.10(3.85,4.37) 4.23(3.97,4.44) 0.060
Insulin (mU/L) 4.58(3.06,7.56) 2.95(1.87,5.10) 0.056 3.86(2.16,6.11) 4.34(2.66,6.06) 0.316
TNF (ng/L) 0.09(0.09,0.55) 0.79(0.45,1.91) < 0.001 0.29(0.09,0.78) 0.55(0.09,1.76) 0.003
Insulin (mU/L) 4.58(3.06,7.56) 2.95(1.87,5.10) 0.056 3.86(2.16,6.11) 4.34(2.66,6.06) 0.316
TNF (ng/L) 0.09(0.09,0.55) 0.79(0.45,1.91) < 0.001 0.29(0.09,0.78) 0.55(0.09,1.76) 0.003
Variables expressed as either Mean (SD) or Median (IQ Range)
TC, Total Cholesterol; HDL-C, High-density lipoprotein-cholesterol;
LDL-C, Low-density lipoprotein-cholesterol; TG, Triglyceride;
TNFa, Tumour necrosis factor-alpha
Table 3 Effect of maternal malaria on birth indices,
placental weight and placental-foetal weight ratio
N = 436 Malaria
Absent
n = 225
Malaria
Present
n = 211
P value
Birth weight (kg) 3.03 0.4 2.87 0.4 0.007
Birth length (cm) 48.97 2.4 48.35 2.0 0.005
OFC (cm) 34.42 1.3 34.07 1.1 0.028
MUAC (cm) 9.98 0.8 9.80 0.9 0.036
Biceps (cm) 3.70 0.8 3.55 0.6 0.032
Placental Weight (g) 557.19 111.5 573.65 119.2 0.186
Placental-foetal weight ratio 5.56 1.5 5.20 1.2 0.019
Placental Weight (g) 557.19 111.5 573.65 119.2 0.186
Placental-foetal weight ratio 5.56 1.5 5.20 1.2 0.019
Variables expressed as Mean (SD)
OFC, Occipito-frontal Circumference;
MUAC, Mid-upper arm circumference
Table 4 Effect of maternal malaria on cord blood
biochemical markers
N = 187 Malaria
Absent
n=9 0
Malaria
Present
n=9 7
P
value
Total cholesterol
(mmol/L)
1.65 0.82, 5.53 1.66 0.71, 6.78 0.136
HDL-C (mmol/L) 0.66 0.32, 2.16 0.63 0.25, 1.91 0.10
LDL-C (mmol/L) 0.70 0.03, 3.19 0.68 0.01, 3.64 0.246
Triglyceride (mmol/L) 0.79 0.20, 2.77 0.62 0.26, 3.52 0.30
Insulin (mU/L) 2.82 0.1, 59.21 2.61 0.26,
50.95
0.677
TNF (ng/L) 2.96 0.01,
97.01
2.23 0.03,
61.58
0.769
IGF-I (μg/l) 74.2 24.0,
150.0
61.3 24.0,
145.0
0.031
TNF (ng/L) 2.96 0.01,
97.01
2.23 0.03,
61.58
0.769
IGF-I (μg/l) 74.2 24.0,
150.0
61.3 24.0,
145.0
0.031
Variables expressed as Median (IQ Range)
HDL-C, High-density Lipoprotein cholesterol;
LDL-C, Low-density lipoprotein cholesterol;
TNFa, Tumour necrosis factor-alpha;
IGF-I, Insulin-like Growth Factor I
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slightly lower than those reported in eastern Nigeria
[17,31,32]. Cord HDL-C and TG levels are about half
that of adults while TC and LDL-C are about one-third,
hence HDL is the major lipid moiety [33,34].
In these pregnant women, there is a marked choles-
terol-lowering impact of malaria, including HDL and
LDL, but triglyceride levels were unaffected. These find-
ings corroborate older reports of lower TC and HDL
associated with acute malaria but in that setting higher
TG [35]. A study of lipid profiles associated with acute
malaria in non-pregnant people has shown higher TG
but no change in TC [36]. The mechanisms involved in
changes in lipid profile associated with malaria are still
unclear. In vitro experiments have shown a selective
uptake of HDL-C by Plasmodium falciparum indicating
that the HDL-C fraction appears to be a major lipid
source for parasite growth [37] and increased intra-para-
sitic cholesterol and phospholipid levels [38]. P. falci-
parum is unable to synthesize lipids required during its
erythrocytic cycle. Hence there is lipid transport through
membrane flux into the parasite. Therefore, malaria in
pregnancy results in demands for cholesterol from three
sources including: the parasite for its growth and prob-
ably its attachment properties; the placenta for produc-
tion of progesterone to maintain the pregnancy, and the
fetus itself for growth [37,38]. This combination may
lead to low cholesterol levels resulting in prematurity
and low birth weight babies.
Maternal plasma glucose and insulin were unaltered by
malaria; the result contrasts with a previous study in preg-
nant women with acute malaria, who had hypoglycaemia
associated with increased glucose turnover, attributed to
enhanced pancreatic b-cell function [39]. Maternal TNF
concentrations in the second trimester were nine-fold
higher in those with malaria, but only doubled if malaria
occurred in the third trimester. This higher TNF was
found previously in Malawian and Kenyan pregnant
women in peripheral and placental blood [21,40]. However
no associations between TNF and any of the other bio-
chemical parameters or birth size were found.
In contrast this study indicated that malaria had a less
pronounced effect on cord blood parameters: cord lipid
profile, insulin and TNF levels were not altered, findings
not previously described in an endemic malaria area.
However cord IGF-I levels were lower.
Effect of maternal malarial on birth indices
In this study, malaria in pregnancy was associated with
younger age, first pregnancy and maternal anaemia, as
Table 5 Correlations (r values) between maternal and cord biochemical markers and birth indices
Biochemical Markers Birth Weight (kg) Birth Length (cm) OFC (cm) MUAC (cm)
Maternal Biochemical Markers (n = 467)
Total cholesterol (mmol/L) 0.194*** 0.108* 0.097 0.204***
HDL-C (mmol/L) 0.062 0.024 0.015 0.141**
LDL-C (mmol/L) 0.179** 0.095 0.080 0.174**
Triglyceride (mmol/L) 0.119* 0.079 0.096 0.076
Glucose (mmol/L) 0.107* 0.098 0.159** 0.090
Insulin (mU/L) 0.150* 0.062 0.023 0.052
Cord Biochemical Markers (n = 187)
Cord Insulin (mU/L) 0.181* 0.003 0.085 0.041
Cord IGFI (μg/L) 0.169* 0.093 0.054 0.193*
* p < 0.05, **p < 0.01, ***p < 0.001
OFC, Occipito-frontal Circumference;
MUAC, Mid-upper arm circumference;
HDL-C, High-density lipoprotein-cholesterol;
LDL-C, Low-density lipoprotein-cholesterol
Table 6 Determinants of birth weight in stepwise
regression
Birth weight ß P-value
Model 1
N = 396
Total Cholesterol
(mmol/L)
0.172 0.001
Model 2
N = 187
Maternal malaria (No/Yes) -0.221 0.007
Model 3
N = 187
Maternal malaria (No/Yes) -0.155 0.05
Cord IGF-I (μg/L) 0.157 0.045
Cord Insulin (mU/L) 0.158 0.042
Model 1 - Maternal Markers and Malaria at recruitment
Model 2 - Cord Markers and Malaria during pregnancy and delivery
Model 3 - Maternal and Cord Markers and Malaria during pregnancy and
delivery
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circumferences as previously reported [41,42].
There was no significant difference between the pla-
cental weight in infants of mothers with malaria and
those without as previously reported by Mcgregor et al
[43]. The finding of lower placenta-foetal weight ratio in
infants born to women with malaria parasitaemia con-
firms previous reports [44,45]. Placental efficiency can
be assessed using the placenta-foetal weight ratio and
the lower ratio in babies of mothers with malaria sug-
gests that their placentas have impaired function.
In babies of mothers with malaria, mean birth weight
was lower by 5.3% compared to babies of mothers with-
out malaria, biceps skinfold thickness by 4.1% and
MUAC by 1.8%, while birth length and OFC were lower
by only 1.3% and by 1% respectively (Table 3). This
agrees with various studies on the impact of malaria in
pregnancy on birth weight (more so than birth length)
which showed that mean birth weights of babies born to
mothers with malaria were lower by 105 g [46], 371 g
[47], 382 g [48] and 461 g [49]. This reduced birth
weight is probably due to placental insufficiency result-
ing from malaria, which leads to intrauterine growth
restriction [45]. There are reports of higher positive
rates of malaria parasite and/or malaria pigment in the
placentae of LBW babies [45,50,51]. In pregnant women
with malaria, it has been observed that there is accumu-
lation of infected red blood cells and increased maternal
phagocytic cells, especially monocytes in the maternal
vascular area of the placenta (the intervillous space) to
much higher densities than in the peripheral blood. In
addition, there is placental sequestration of the tropho-
zoite and schizont stages, which are absent from the cir-
culation [52]
. The inadequate uteroplacental and
umbilical blood flow, and alterations in the transplacen-
tal transfer of glucose or production of foetal insulin
result in LBW babies due to foetal growth restriction
[53]. It has been suggested that disturbed placental
folate metabolism, placental lactogen, IGF/somatomedin,
and somatostatin-like substances, which influence foetal
growth, may also play an important role [54].
Very few studies have assessed the impact of malaria
in pregnancy on other growth parameters at birth apart
from birth weight. In agreement with our findings,
Kalanda et al documented significantly lower mean
birth weight, length, head circumference and mid upper
arm circumference in babies of mothers with malaria
[53].
Determinants of birth size
Birth weight remains the single most important determi-
nant of neonatal and infant survival and health. It is
therefore important to understand factors that may
influence birth weight. In this study, birth weight was
strongly related to maternal total cholesterol, LDL-C,
and less so to maternal triglyceride, glucose and insulin.
This is in contrast to findings in Nigerian newborns
about 15 years ago when maternal lipid samples were
obtained at delivery but not during pregnancy [31,33].
This study now indicates that variations in maternal
cholesterol metabolism appear to have a significant
effect on foetal growth during pregnancy and hence
birth size. Maternal TG has a lesser impact, although in
women with altered glucose tolerance, serum TG con-
centrations have been shown to predict birth weight
[11,13]. Additionally maternal glucose and insulin have
a less important impact on foetal growth. In cord blood,
insulin and IGF-I were related to birth weight. Both
insulin and IGF-I are major growth factors in foetal life
as shown by monogenic disorders that affect foetal insu-
lin secretion [55] and IGF-I generation [56-58].
The regression models highlight the most significant
factors that determine birth weight, including maternal
total cholesterol, malaria status and cord insulin and
IGF-I levels. These findings are corroborated by a recent
report that showed that maternal and cord IGF-I were
reduced in women with placental malaria compared to
those without [59].
Conclusions
In the setting of endemic malaria, maternal total choles-
terol during pregnancy and cord blood insulin and IGF-
I levels are important markers of foetal growth restric-
tion and reduced birth size likely mediated through pla-
cental insufficiency.
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